Study S001098

CGM Substudy, Addendum 2, of the Following Exenatide LAR Protocol 2993LAR-105: A Randomized, Open-Label, Multicenter, Comparator Controlled Study to Examine the Effects of Exenatide Long-Acting Release on Glucose Control (HbA1c) and Safety in Subjects With Type 2 Diabetes Mellitus Managed With Diet Modification and Exercise and/or Oral Antidiabetic Medications)

ClinicalTrials.gov record

Registration

Registration: NCT00803920
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 8
Start: 2006-12
Primary completion: 2008-02
Lead sponsor: HealthPartners Institute
Conditions: Type 2 Diabetes Mellitus
Results posted: FALSE

Registered primary outcomes

Characterize glucose control using periodic CGM in subjects participating in protocol 2993LAR-105 at the International Diabetes Center study site. [2 week periods of time - 3 times during study:]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.